The expansion of clinical trials evaluating proton-based radiotherapy could elucidate its benefits and increase its access across the US.
Jason K. Molitoris, MD, PhD
Advertisement
Articles by Jason K. Molitoris, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Study Redefines Functional High-Risk Multiple Myeloma in Modern-Therapy Era
2
ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates
3
Sequencing Treatment after EV-Pembro in Urothelial Carcinoma
4
Managing Safety and Infection Risk With Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
5